In particular, a monoclonal full-length antibody (Pozzi et al. 2020) and asingle chain antibody (Pozzi et al. 2019), both specifically directed against the RRM1domain of TDP-43, were generated and tested in ALS/FTLD mouse models. Here, TARDBP is linked to amyotrophic lateral sclerosis.